News Pathos AI signs two cancer deals with Alphamab and AZ Pathos AI has grown its oncology pipeline by licensing a bispecific ADC from Alphamab for $125m and partnering a breast cancer drug from AstraZeneca.
News New UK PM shuts down science and tech department In the midst of appointing his Cabinet, new UK Prime Minister Andy Burnham has scrapped the Department for Science, Innovation and Technology (DSIT).
News BMS, NVIDIA to build 'most powerful' AI factory BMS and NVIDIA say their new AI alliance will deliver the life science industry's most powerful centralised AI supercomputer.
News Aureka offers open-source AI module for drug discovery Many AIs used in drug discovery are provided by big tech companies at a cost, but a small US and China-based techbio is taking a different tack.
News AI-powered triage is coming to the NHS App The NHS will include an AI-powered triage tool in the NHS App in an attempt to cut waiting lists and improve care for millions of patients.
News AI agents can beat doctors in clinical decision-making Two AIs have shown they can match doctors across diagnostic and treatment tasks, but their developers say they aren't ready yet for real-world use.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.